MSD BELGIUM secures contract for Pharmaceutical products - Pharmaceutical specialties based on vaccines against the hepatitis A virus against the hepatitis B virus and combined vaccines against the hepatitis A virus and against the hepatitis B virus

Belgium, April 27 -- Belgium based MSD BELGIUM has secured contract from Healthcare Public Procurement (HeCaPP) for Pharmaceutical products - Pharmaceutical specialties based on vaccines against the hepatitis A virus against the hepatitis B virus and combined vaccines against the hepatitis A virus and against the hepatitis B virus. The value of the contract is worth 42710878 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....